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Available online 8 March 2016Several lines of evidence indicate that antibody-dependent cellular cytotoxicity (Wren et al., 2013) is important
in the pathogenesis of HIV-1 infection. Namely, ADCC is induced during natural HIV-1 infection or in HIV-1 vac-
cine studies, the latter demonstrated by the RV144 vaccine trial. To expedite the assessment of ADCC in studies of
HIV, we have developed a high throughput assay.We have optimized the rapid ﬂuorometric antibody-mediated
cytotoxicity assay (RFADCC) by transfecting the EGFP-CEM-NKr cell line to constitutively express SNAP-tagged
CCR5. This cell line can then serve as a source of HIV-speciﬁc targets when coated with monomeric gp120,
spinoculated with inactivated intact virions, infected by cell-free viral diffusion or infected by cell-to-cell trans-
mission of virus. The optimized strategy has two signiﬁcant advantages over the original RFADCC method:
First, the preparation of detectable target cells is less labor intensive and faster as it does not rely on multiple
staining and washing steps for target cells. Second, because the target cell markers GFP and SNAP are constitu-
tively expressed, the assay provides highly reproducible data. These strengths make the optimized RFADCC
assay suitable not only for studies of HIV-1 speciﬁc cytotoxicity but also for studies of cell–cell transmission of
virus. In conclusion, this assay provides a new generation T cell line that can expedite large clinical studies as
well as research studies in humans or non-human primates.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
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HIV-1 virus1. Introduction
ADCC in HIV-1 has been studied for over 20 years (Wren et al.,
2013), but interest in the HIV-speciﬁc response was prompted by ﬁnd-
ings from the recent RV144 clinical vaccine trial showing ADCC, togeth-
er with low IgA, as a correlate of protection (Bonsignori et al., 2012;
Haynes et al., 2012). Also, observations obtained in several natural HIV
infection systems (Chung et al., 2011; Ferrari et al., 2011) have
highlighted a key role of ADCC activity in the immune response against
the virus. A number of experimental assays have been standardized and
utilized to characterize human or non-human primate antibodies for
HIV-speciﬁc cytotoxicity.Many of the ADCC assaysmeasure the potency
of antibodies to mediate killing of virus-infected target T cells, mainly
CEM NKr CCR5, by healthy, uninfected donor PBMC effector cells.
These assays rely on the quantiﬁcation of target cells that are pre-
labeled with traceable compounds, the loss of which indicates a de-
crease in membrane integrity or decrease in target cell viability. AsVirology of the University of
1201 Baltimore, MD, USA.
andi),
. This is an open access article underADCC readouts, these assays exploit critical steps of cytotoxicity, such
as release of 51chromium due to apoptotic killing of speciﬁc targets
(Ahmad et al., 2001), release of granzyme B by activated effectors
(Pollara et al., 2011), loss of intracellular carboxyﬂuorescein diacetate
succinimidyl ester (CSFE) due to disruption of target cell membrane in-
tegrity (Gomez-Roman et al., 2006) or decrease in luciferase signal due
to direct killing of virus-bearing luciferase targets (Liao et al., 2013;
Pollara et al., 2014). In addition, a novel ADCC assay that incorporates
a CD16+ NK effector cell line and a CD4+ T-cell line expressing HIV
Tat-inducible luciferase (Alpert et al., 2012) has been utilized to identify
the inverse correlation between ADCC titers and risk of infection in the
RV144 trial (Bonsignori et al., 2012; Haynes et al., 2012). More recently,
another ADCC assay based on the quantiﬁcation of killed targets using
the cell marker eFluor670 and a live/dead dye was reported (Richard
et al., 2014). Although these assays have provided important informa-
tion about HIV pathogenesis or design and delivery of HIV vaccines,
most are typically labor intensive and time consuming. Likewise, the
RFADCC assay employed by our group to characterize mAbs speciﬁc
for highly conserved regions of HIV-1 envelope exposed during viral
entry (Gomez-Roman et al., 2006; Guan et al., 2013; Acharya et al.,
2014) is equally demanding. However, becauseﬂow cytometry analyses
have allowed a detailed understanding of the phenotype of the cells in-
volved, we modiﬁed the original RFADCC assay to streamline thethe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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this end, we optimized our RFADCC assay to avoid the need for the cum-
bersome and multiple staining steps and washings, including eliminat-
ing the harsh target cell membrane staining with PKH26. The modiﬁed
assay now involves only one rapid staining step and is highly useful for
the systematic analysis of ADCC using target cells either sensitized with
gp120, spinoculated with intact HIV virions, infected by cell-free virus
or by cell-to-cell transmission of virus.
2. Material and methods
2.1. Cell lines, viruses and monoclonal antibodies (mAbs)
The human T lymphoblastoid cell lines CEM NKr CCR5 (Howell
et al., 1985) and EGFP-CEM-NKr (Kantakamalakul et al., 2006)
were obtained from the National Institute of Allergy and Infectious
Diseases (NIAID) Reagent Repository. CEM NKr CCR5 cells were
maintained in RPMI 1640 medium with glutamine and supplement-
ed with 10% fetal bovine serum (FBS), HEPES buffer (Sigma) 10 mM,
sodium pyruvate (Sigma) 500 μM, β-Mercaptoethanol (GIBCO)
50 μM and gentimicin (GIBCO) 50 μg/ml (termed R10 medium).
The EGFP-CEM-NKr and EGFP-CEM-NKr-CCR5-SNAP cells were
maintained in R10 medium supplemented with neomycin G418
(Gemini, Bio-Products) at 800 μg/ml and 1.5 mg/ml, respectively.
For cell-bound virion studies, we employed AT-2 inactivated HIV-1
BalSuPT1-CCR5 CL.30 at a multiplicity of infection (MOI) of 5. This
MOI was calculated using analytical information provided by Dr. Jeffery
Lifson (National Cancer Institute at Frederick, Frederick, MD), who
generously supplied this preparation. For infection by cell-free virus or
cell–cell virus spread, we used HIV-1 Bal infectious molecular clone
(NIH AIDS Reagent & Reference Reagent Program Lot. 9 021056)
(Gartner et al., 1986) andHIV-1 Bal infectiousmolecular cloneproduced
in SupT1-R5 cells (Ray et al., 2014) respectively. The human mAbs in-
cluded in the study were isolated from our Natural Virus Suppressors
(NVS) cohort (Sajadi et al., 2007; Sajadi et al., 2009) and characterized
to be speciﬁc for highly conserved regions of CD4-triggered gp120
(Guan et al., 2013): N5-I5 targets the mAb A32-like epitope surface
around β2, β111-strands and α0- and α1-helixes of layers 1 and 2 of
the inner domain of gp120 (Moore et al., 1994; Finzi et al., 2010;
Pancera et al., 2010; Acharya et al., 2014; Gohain et al., 2015); C11
targets a distinct and discontinuous epitope on the seven-stranded β-
platform and a residue in the extended C terminus of the gp120 mole-
cule (Moore et al., 1994; Pancera et al., 2010; Pollara et al., 2013;
Gohain et al., 2015); N12-i12 targets the gp120 co-receptor binding
site (CoRbs) (Guan et al., 2013); N10-U1 targets the immunodominant
domain of gp41 (unpublished result). The anti-respiratory syncytial
virus mAb Synagis (MedImmune) was used as a negative control in
most experiments.
2.2. Production of EGFP-CEM-NKr cells stably expressing CCR5-SNAP
EGFP-CEM-NKr cells (2 × 106) were transfected with 2 μg of Tag-lite
pSNAP-CCR5 vector (pSNAPCCR5, htfr) with the Amaxa nucleofector
and Amaxa Cell line Nucleofector Kit C (Cat. VCA-1004) according to
the manufacturer's instructions. EGFP-CEM-NKr cells were maintained
with R10 medium supplemented neomycin at 800 μg/ml during and
after transfection due to the EGFP vector resistance. On day 2 post-
transfection, the expression of CCR5-SNAP molecule on the cell surface
was assessed by ﬂow cytometry of cells stained with PE anti-CCR5
mAb 2D7 (BD Pharmingen Cat. 555993).
The CCR5-positive EGFP-CEM-NKr cells were subjected to three
rounds of selection by labeling with the 2D7 mAb and sorting with a
FACSARIA II (Becton Dickinson, BD). Finally, when it was determined
that CCR5 expression peaked on EGFP-CEM-NKr CCR5-SNAP cells,
clones that showed distinct high levels of CCR5 expression were se-
lected by limiting dilution. The expression of the SNAP tag was alsoassessed by indirect staining with rabbit anti-SNAP-Tag pAb
(GenScript Corporation Cat. A00684) and PE F(ab′)2 donkey anti-
rabbit IgG (eBioscience Cat. 12-4739) (data not shown). EGFP-
CEM-NKr-CCR5-SNAP cells were passaged twice per week, with a
higher neomycin dose (1.5 mg/ml) in order to better induce the
CCR5-SNAP molecule expression on the cell surface and monitored
weekly by ﬂow cytometry. Quantibrite PE beads (Phycoerythrin Fluo-
rescence Quantiﬁcation Kit, BD Bioscience) were used to estimate the
number of CCR5 and CD4 molecules present per EGFP-CEM-NKr-
CCR5-SNAP cell, with CEM NKr CCR5 cells used as a reference.
2.3. Optimized RFADCC assay and cell surface staining
To optimize the RFADCC assay (Gomez-Roman et al., 2006) for high
throughput efﬁciency, the regular double staining with the membrane
PKH-26 dye and the intracellular carboxyﬂuorescein diacetate,
succinimidyl ester (CSFE) dye were replaced with themembrane stain-
ing of the CCR5-SNAP-tag and the constitutive intracellular expression
of GFP. For the ADCC protocol (Fig. 2), EGFP-CEM-NKr-CCR5-SNAP
target cells were stained with the ﬂuorescent substrate SNAP-
Surface Alexa Fluor 647 (New England BioLabs Cat. S9136S) for
20 min at 37 °C with or without coating of monomeric HIV-1 Bal
gp120 (50 μg/ml). For the studies with spinoculated virus, the cells
were ﬁrst stained with the SNAP-Surface dye and then spinoculated
with the AT-2 inactivated Bal HIV-1 virus at 2000 RPM for 2 h at
12 °C. Gp120-sensitized, virus-spinoculated or infected EGFP-CEM-
NKr-CCR5-SNAP target cells were then washed twice with cold R10
medium and added to a 96-well V-bottom plate (5000 cells/well).
A ﬁnal volume of 100 μl/well of antibody dilution was added and in-
cubated with sensitized targets for 15 min at room temperature. A
total of 250,000 puriﬁed human effector PBMC isolated by Ficoll-
Paque from the whole blood of healthy human donors cells were
added to each well at an effector/target (E/T) ratio of 50:1. After in-
cubation at 37 °C in 5% CO2 for 2 h (gp120-coated) or 3 h (virus-
spinoculated or infected cells), cells were washed with phosphate-
buffered saline (PBS) containing 1% FBS (wash buffer), and ﬁxed in
1% paraformaldehyde. Samples were analyzed at approximately
35,000 events per sample on an LSRII Fortessa ﬂow cytometer (BD
Biosciences). Doublets were excluded by forward-scatter area
(FSC-A) versus forward-scatter height (FSC-H). Data were analyzed
by FlowJo software (Tree Star, Ashland, OR). ADCC activity (=%
cytotoxicity) is deﬁned as the percentage of EGFP-CEM-NKr-CCR5-
SNAP target cells that lose GFP staining but retain the CCR5-SNAP
tag dye.
For cell surface staining, HIV-1 gp120-sensitized and infected EGFP-
CEM-NKr-CCR5-SNAP target cells were incubated for 30min at RT with
1 and 5 μg/ml, respectively, of Alexa-Fluor 647-conjugated mAbs C11,
N5-i5 or N12-i2 in PBS. Target cells spinoculated with Bal AT-2
inactivated virus were incubated for 30 min at RT, respectively with
2 μg/ml of Alexa-Fluor 594-conjugated mAbs C11, N5-i5, N12-i2 or
N10U1 in PBS. Cells were then washed once with wash buffer and
ﬁxed in a 1% paraformaldehyde.
2.4. HIV-1 infection of EGFP-CEM-NKr-CCR5-SNAP cells
To prepare the EGFP-CEM-NKr-CCR5-SNAP cells for virus infection
assays, the cells were split 1:2 the previous day. Spinoculation was per-
formed in a 96-well U-bottomplate by resuspending 5 × 105 target cells
in amedium containing 240 ng of infectious virus (control cells were in-
cubated without virus), as measured by HIV-1 p24 antigen capture
ELISA. Mixtures of target cells and virus were centrifuged for 2 h at
2000 RPM at 12 °C. Afterward, the viral inoculum was diluted 1:2 in
R10 medium containing G418 1.5 mg/ml, and the cells and virus were
placed into one well of a 12-well ﬂat-bottom plate. The cells were
then cultured adding fresh medium every 2 days. At 5 days post-
infection, EGFP-CEM-NKr-CCR5-SNAP cells were harvested, washed
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stained for RFADCC as previously described; the second one was used
to quantify the efﬁciency of infection andmAb binding. For intracellular
p24 staining, the cells were washed once with PBS and stained with
Live/Dead Fixable Near-IR Dead Cell Stain (Molecular Probes) and
with 5 μl of (APC)-conjugated mouse anti-CD4 OKT4 mAb (eBioscience)
for 30 min at RT. After a wash in wash buffer, the cells were then ﬁxed
and permeabilized using the Cytoﬁx/Cytoperm Kit (BD-PharMingen,
San Diego, Calif.) for 20 min at 4 °C. Subsequently, the permeabilized
cells were washed once with the buffer provided by the manufacturer,
resuspended and stained for 30 min at RT with 5 μl (PE)-conjugated
mouse anti-p24 mAb (KC57-RD1; Beckman Coulter, Inc.). After two ad-
ditional washes, HIV-1- or mock-infected PBMC was analyzed with an
LSRII Fortessa ﬂow cytometer (BD Biosciences) and data analysis was
performed with FlowJo software (Tree Star, Inc., San Carlos, Calif.).
Live and GFP positive cells were analyzed for intracellular p24-Ag and
surface CD4.
2.5. HIV-1 cell–cell transmission in EGFP-CEM-NKr-CCR5-SNAP cells
Cell–cell virus transmission experimentswere performed using CEM
NKr CCR5 cells as virus-infected donor cells and EGFP-CEM-NKr-CCR5-
SNAP cells as virus-acceptor targets. Accordingly, CEM NKr CCR5 cells
were infected with HIV-1 Bal Molecular Clone and frozen at 3 days
post-infection at the peak of infectivity (23% p24+ cells, Fig. 6 Panel C
0 h). The day before the co-culture experiment, the donor cells were
thawed, rested overnight in R10 medium at 37°, 5% CO2 and then
washed twice with PBS, keeping the supernatant as a control (Fig. 6
Panel A-Free virus Transwell-FVT). The infected CEM NKr CCR5 donors
were plated with the acceptor EGFP-CEM-NKr-CCR5-SNAP targets at a
ratio 1:1 (1 × 106 donor: 1 × 106 acceptor) for 7 days (Fig. 6 Panels A-
C). For reference, the donor and acceptor cells were cultured at the
same ratio in a separated trans-well chamber (12 mm Transwell® with
3.0 μmporepolycarbonatemembrane insert (Corning#3402) to evaluate
the ability of the donor-produced virus to infect the acceptor cells in a
cell-free manner (Fig. 6 Panel A-Co-Culture Transwell-CCT). The readout
of the newly infected targetswas the count of GFP+p24+CD4+ cells over
various time points. Every 24 h, an aliquot of the donor/acceptor cellFig. 1.Generation and characterization of EGFP-CEM-NKr-CCR5-SNAP cells. Left panel. EGFP-CEM
Tag-lite pSNAP-CCR5 vector (pSNAP-CCR5, htfr). A–C. GFP and CCR5 expression in parental
Labeling with surface SNAP tag-Alexa Fluor-647 dye vs. GFP expression in the three cell lines
SNAP cells in comparison to CEM NKr CCR5 were assessed by ﬂow cytometry with Quantibritecombination was harvested and stained for the expression of surface
CD4 and intracellular p24, as previously described in the previous section.
3. Results
3.1. Generation and characterization of the levels of CCR5 molecules on the
EGFP-CEM-NKr-CCR5-SNAP cell line
Keeping the original RFADCC assay format, we developed a more
reliable and rapid approach to label the CEM target cells. To eliminate
CSFE staining, we employed EGFP-CEM-NKr cells (Kantakamalakul
et al., 2006) that constitutively express cytosolic GFP but are nega-
tive for CCR5 expression (Fig. 1, Panel A compared to Panel B).
Then, we engineered the EGFP-CEM-NKr cells to stably express the
fusion protein N-terminal SNAP-tagged CCR5 on the cell surface.
After three rounds of sorting and limiting dilution culture, we suc-
cessfully isolated a stable GFP+ clone that expressed CCR5-SNAP
tag on the surface, as shown in Fig. 1, Panel C. Of note, the transfec-
tion of CCR5-SNAP did not affect the level of GFP expression (Fig. 1,
compare panels B vs. C). More importantly, the CCR5-SNAP tag con-
struct provided the advantage of using an anti-SNAP-tag (linked to
CCR5) dye, which is relatively bright, non-toxic and speciﬁc for
cell-surface (Fig. 1, Panel F), eliminating the background from non-
CCR5-SNAP tag expressing cells (Fig. 1, Panel D and E). The SNAP
tag provided the opportunity to use a second ﬂuorochrome (SNAP-
Surface Alexa Fluor 647) needed to identify the killed target cells in
the RFADCC assay (Fig. 1, Panel F). We then determined the levels
of CCR5 and CD4 molecules expressed on the cell surface with cali-
bration beads and found that the new cell line expressed a physio-
logic level of CCR5 (Fig. 1, right panel blue bars). Additionally, we
selected for cells with relatively high CD4 levels, which is typically
useful for studying HIV-1 infection (Fig. 1, right panel red bars).
3.2. Optimized RFADCC assay with gp120-sensitized
EGFP-CEM-NKr-CCR5-SNAP cells
To compare the original RFADCC with the modiﬁed RFADCC, CEM
NKr CCR5 cells were stained with PKH26 and CSFE, while EGFP-CEM--NKr-CCR5-SNAP cells were generated by stable transfection of EGFP-CEM-NKr cellswith
CEM-NKr-CCR5, EGFP-CEM-NKr and transfected EGFP-CEM-NKr-CCR5-SNAP cells. D–F.
. Right panel. The levels of CCR5 and CD4 molecules expressed on EGFP-CEM-NKr-CCR5-
PE calibration beads.
Fig. 2. Schematic representation of the new RFADCC assay outline conductedwith EGFP-CEM-NKr-CCR5-SNAP cells. The optimized assaywas modiﬁed from Gomez-Roman et al. (2006).
A. For gp120-based ADCCassay, EGFP-CEM-NKr-CCR5-SNAP cellswere stainedwith SNAP-SurfaceAlexa Fluor 647 for 20min at 37 °Cwith orwithoutmonomeric HIV-1 gp120. B. For AT-2
inactivated virus-based ADCC assay EGFP-CEM-NKr-CCR5-SNAP cells were stained with Alexa Fluor 647-SNAP tag dye ﬁrst and then spinoculated with the inactivated virus. C. For IMC-
infected targets-based ADCC assay, EGFP-CEM-NKr-CCR5-SNAP were spinoculated with IMC, cultured for 5 days, washed twice and then stained with Alexa Fluor 647-SNAP tag dye.
Sensitized cells were incubated with dilutions of antibodies for 15 min at room temperature (RT) and subsequently with PBMC as effector cells for 2 or 3 h at 37 °C. Cells were then
washed and ﬁxed in 1% paraformaldehyde. The readout is the loss of GFP, as a direct measure of the percentage of target cells cytotoxicity mediated by the mAbs. After coating with
monomeric HIV-1 Bal gp120 and adding PBMC as effector cells, we measured the ADCC activity of a reference HIV-1 mAb, C11. The cytotoxicity readout in the original RFADCC was
measured as loss of CSFE, while in the modiﬁed RFADCC it was the loss of GFP.
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dye as summarized in Fig. 2.
As shown in Fig. 3 Panel A, the two cell lines behaved similarly, hav-
ing a comparable percentage of target cells migrating from the double
stained population into the region containing the killed target cell pop-
ulation, positive only for PKH-26 or SNAP-Alexa Fluor 647 respectively.
Subsequently, the new target cells were employed tomeasure the ADCC
activity of two additional human anti-gp120 mAbs. As a negative con-
trol, we used an unrelated mAb, Synagis, speciﬁc for respiratory syncy-
tial virus (RSV). The assay was performed by adding the double-labeled
target cells to mAbs dilutions, allowing them to bind, and then adding
PBMC as effectors. As shown in Fig. 3 Panel B, the new cellular system
was able to detect the speciﬁc anti-gp120 ADCC activity of C11, N5-i5
and N12-i2 mAbs, with values comparable to the original RFADCC
(Guan et al., 2013). As expected, the RSV mAb was negative in the in-
duction of cytotoxicity. In addition, we evaluated the ability of the
gp120-coated EGFP-CEM-NKr-CCR5-SNAP cell line as a tool to study
the binding of the same mAbs. As shown in Fig. 3, we detected a very
strong signal for all the Alexa Fluor 647-labeled antibodies (C11, N5-i5
and N12-i2), speciﬁc for the binding of gp120 molecules on EGFP-
CEM-NKr-CCR5-SNAP cells (Panels C‐–E), compared to the negative
control of uncoated cells (dashed greygray curve). Interestingly, theintensity of the binding detected in the new cell line was comparable
to the standard gp120-coated CEM NKr CCR5 cells (Fig. 3 Panels F-H).
3.3. Optimized RFADCC assay with virion
bound-EGFP-CEM-NKr-CCR5-SNAP cells
In order to evaluate the possibility of using the new cell line to
identify mAbs that mediate ADCC against cell-bound intact HIV, we
spinoculated the EGFP-CEM NKr CCR5-snap cells with AT-2 inactivated
HIV-1 Bal, as described in the Materials and Methods section (Rossio
et al., 1998; O'Doherty et al., 2000). This approach allows the evaluation
of immunogenicity of envelope epitopes exposed upon binding of cell
surface CD4. As shown in Fig. 4 (left panel) in the modiﬁed system,
the reference antibodies were able to induce strong cytotoxicity against
cell-bound virus. The ADCC values were comparable to those obtained
in the original RFADCC with CEM NKr CCR5 cells bound with the same
virus (Guan et al., 2013). Moreover, we quantiﬁed the efﬁciency of the
spinoculation-mediated virus binding by testing bindingwith the refer-
ence mAbs labeled with Alexa Fluor-594. We were able to detect a
strong signal for all the antibodies tested (Fig. 4 right Panels A-C). Of
note for the virus-bound cells, the values for ADCC activity and binding
ability were lower than with the gp120-coated cells because of the
Fig. 3.ADCC assay andmAbs surface staining conductedwith cells coatedwithHIV-1 Bal gp120. A. Comparison of RFADCCassay layoutwith CEMNKrCCR5 vs. EGFP-CEM-NKr-CCR5-SNAP
cells. CEMNKr CCR5were stained with PKH-26 and CSFE (Gomez-Roman et al., 2006), while EGFP-CEM-NKr-CCR5-SNAP cells were stainedwith Alexa Fluor 647-SNAP tag dye. Killing by
C11mAb (1 μg/ml) is determined as loss of CSFE in PKH26-positive CEMNKr CCR5 cells or loss of GFP in SNAP-positive EGFP-CEM-NKr-CCR5-SNAP cells. B. Cytotoxicity curves for gp120-
coated EGFP-CEM-NKr-CCR5-SNAP. The ADCC results are representative of three independent assays and the bars indicate the range of the values of cytotoxicity of duplicate samples. The
binding of 1 μg/ml Alexa-Fluor 647-conjugated mAbs C11 (C and F), N5-i5 (D and G) or N12-i2 (E and H) was compared in gp120-coated-CEM NKr CCR5 vs. EGFP-CEM-NKr-CCR5-SNAP
cells.
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bers of cells that can be bound synchronously by the virus in vitro (com-
pare Fig. 3 [gp120] vs Fig. 4 [virus bound]).Fig. 4. ADCC assay using cells spinoculated with AT-2 inactivated HIV-1 BaL virions. Left panel
spinoculated with HIV-1 Bal AT-2 virus at 2000 rpm for 2 h at 12 °C. After two washes, cells w
then PBMC were added to the reaction for 3 h at 37 °C. At the end of the incubation, the sa
cytometry. The ADCC results are representative of three independent assays and the bars
efﬁciency of the spinoculation was evaluated by cell surface staining with 2 μg/ml Alexa Fluor-3.4. Infection and optimized RFADCC assay with
EGFP-CEM-NKr-CCR5-SNAP cells
In order to determinewhether themodiﬁed cell linewas suitable for
virus infection and thus use in an infected-cell RFADCC assay, we. EGFP-CEM-NKr-CCR5-SNAP cells were labeled with Alexa Fluor 647-SNAP tag and then
ere incubated with dilutions of mAbs (C11, N5-i5, N12-i2 or Synagis) for 15 min at RT,
mples were washed with PBS, ﬁxed with 1% paraformaldehyde and analyzed by ﬂow
indicate the range of the values of cytotoxicity of duplicate samples. Right panel. The
594-conjugated mAbs C11 (Panel A), N5-i5 (Panel B) or N12-i2 (panel C).
Fig. 5.ADCC assay using cells infectedwithHIV-1 BaL IMC. Left panel. EGFP-CEM-NKr-CCR5-SNAP cellswere spinoculatedwithHIV-1 Balmolecular clone at 2000 rpm for 2 h at 12 °C. After
5 days of co-culturewith the virus, cellswerewashed twice, labeledwith Alexa Fluor 647-SNAP tag dye and incubatedwith dilutions ofmAbs (C11, N5-i5, N10-U1 or Synagis) for 15min at
RT, then PBMC were added to the reaction for 3 h at 37 °C. At the end of the incubation, the samples were washed with PBS, ﬁxed with 1% paraformaldehyde and analyzed by ﬂow
cytometry. The ADCC data represent the typical results obtained in three independent experiments. Upper right panel. The efﬁciency of the infection was evaluated by staining of the
cells with live/dead (not shown), CD4-APC and p24-PE. Lower right panel. Binding of infected EGFP-CEM-NKr-CCR5-SNAP cells with 5 μg/ml Alexa Fluor-647-conjugated mAbs C11
(panel A), N5-i5 (panel B) or N10U1 (panel C).
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B Bal infectious molecular clone (IMC), as previously described (Alpert
et al., 2012). At 5 days post-infection Bal-spinoculated EGFP-CEM-
NKr-CCR5-SNAP cells presented a high cellular viability (approximately,Fig. 6. EGFP-CEM-NKr-CCR5-SNAP cells: New tool to study the cell–cell virus spread. A. Schema
CCR5 cells, infectedwithHIV-1 Balmolecular clone,were used at the peak of infection as virus d
transmitted cell to cell. Donors and targets were plated together to allow the spread of the
Background of cell-free virus spread was determined with donors and targets separated in T
donor cells. B. and C. The count of GFP+/p24+/CD4+ or − cells was monitored for 7 days from90%), comparable to control uninfected cells (data not shown). The rate
of infection was about 20% (as shown by the presence of p24 in Fig. 5
right upper panel). As expected, a high percentage of p24+ cells
down-regulated the surface expression of the CD4 molecule (Veillettetic representation of the experimental design (modiﬁed from Zhong et al., 2013). CEMNKr
onors. EGFP-CEM-NKr-CCR5-SNAP cells were used as virus acceptor targets of the infection
virus, and the readout of the newly infected targets was the count of GFP+/P24+ cells.
ranswell chambers and with targets subjected to supernatants harvested from infected
the beginning of the co-culture by ﬂow cytometry.
57C. Orlandi et al. / Journal of Immunological Methods 433 (2016) 51–58et al., 2014). We employed the infected cells as targets for our high
throughput RFADCC. Interestingly, we were able to detect binding and
cytotoxicity of the CD4i reference mAbs C11 and N5-i5, the epitopes of
which are normally masked in an unbound, native Env trimer
(Acharya et al., 2014; Veillette et al., 2014) (Fig. 5 left panel and right
panels A-B); this is most likely due to the residual surface membrane
CD4 expression in a fraction of p24+ infected cells, rendering them
sensitive to ADCCwith these CD4i mAbs (Veillette et al., 2014). In ad-
dition, we revealed low level binding and ADCC activity for N10-U1,
which is speciﬁc for the immunodominant domain of gp41 (Fig. 5 left
panel and right Panel C). As expected, Synagis was negative for the
ADCC activity and for binding to Bal infected EGFP-CEM-NKr-CCR5-
SNAP cells (data not shown). This result constitutes additional evi-
dence that the chimeric CCR5-SNAP tag is able to act as a functional
co-receptor for HIV-1 during virus entry and fusion with the cellular
membrane.
3.5. A new tool to determine cell–cell virus spread
HIV-1 has been shown to be capable of two modes of propagation:
direct infection by cell-free virions and cell-to-cell transmission
(Sattentau, 2008). Notably, cell-to-cell spread from infected to non-
infected cells occurs through the formation of virological synapses
(McDonald et al., 2003; Sattentau, 2008; Hubner et al., 2009) and has
been shown to be a more rapid and efﬁcient mechanism compared to
free virus-cell diffusion. This feature supports the hypothesis that cell–
cell transmission may be a relevant mode of virus dissemination in in-
fected individuals (Dimitrov et al., 1993; Carr et al., 1999; Chen et al.,
2007; Sourisseau et al., 2007). Thus, it is important to have a tool that al-
lows themethodical evaluation of mAbs or other molecules compatible
with this type of infection. Accordingly, we designed an experimental
method based on Zhong et al's. (2013) system in which the authors
compared the efﬁciency of HIV-1 transmission by cell-free virus vs.
cell–cell transmission in co-cultures. To evaluate it with our EGFP-
CEM-NKr-CCR5-SNAP cell line, we persistently infected CEM NKr CCR5
cells with HIV-1 Bal molecular clone, using these cells as donors of
replication-competent virus at the peak of the infection, as found by
the levels of p24 expression (Fig. 6, Panel C, Donor-0 h). With the
EGFP-CEM-NKr-CCR5-SNAP cells as the virus infectable targets, these
cells were directly co-cultured with the virus infected donors or sepa-
rated from the donors by a trans-well membrane for 168 h. An addition-
al control was the supernatant harvested from the infected CEM NKr
CCR5 cells just before the experiment (summarized in scheme Fig. 6,
Panel A). The readout of the assay was the count of GFP+/p24+ cells,
representing newly infected target cells. As shown in Fig. 6, Panel B,
the co-culture of infected donors with uninfected targets allowed the
transmission of the virus through cell–cell contacts, reaching a peak of
GFP+/p24+ cell count at 48 h. Additionally, ﬂow-cytometry analysis
allowed the characterization of the levels of expression of CD4 on the
surface of the newly infected GFP+/p24+ cells. In Fig. 6, Panel C, we
show that by 48 h of co-culture, levels of CD4 on the cell surface had de-
creased from100% to 5% and by 72 h, CD4 levels were further decreased
to 1%. Thus, using this culture system, the physical contact of cells was
much more efﬁcient in spreading the infection (Fig. 6, Panel B), than
culturing uninfected cells with cells actively producing virus or with
cell-free virus-containing supernatant, as shown in Fig. 6, Panel B.
4. Discussion
The RFADCC assay has provided an important contribution in the
characterization of antibodies that mediate strong cytotoxicity against
HIV-1 sensitized cells. Here we describe an optimization of the original
RFADCC that has been modiﬁed in the following ways: to replace the
time consuming staining of target cells with two dyes and subsequent
multiple washings, we took advantage of the cell line EGFP-CEM-NKr
(Kantakamalakul et al., 2006) that constitutively expresses one of thetwoﬂuorochromes needed to identify target cells. Next, to include a sec-
ond ﬂuorochrome and replace the PKH26 dye, which is relatively toxic,
we transfected cells with a SNAP tag-linked CCR5, and then stained the
targetswith anAlexa Fluor dye directed to the SNAP tag. Theﬁrst part of
the ADCC procedure now is dramatically faster and more reproducible
(summarized in Fig. 2). Moreover, as we show in Figs. 3-4, the results
obtained both in gp120-coated or AT-2 inactivated virus bound-cells
are very comparable to each other and consistent with what we had
previously reported (Guan et al., 2013). We also demonstrated that
the new cell line can serve as a susceptible target for HIV-1 infection
and subsequently be employed as targets for ADCC activity mediated
by anti-HIV-1 antibodies (Fig. 5). These results are signiﬁcant for high-
throughput evaluation of antibody responses to epitopes exposed earli-
er during viral entry and later during viral budding post-infection. Final-
ly, we assessed the possibility of utilizing EGFP-CEM-NKr-CCR5-SNAP
cells to evaluate cell–cell spreading of HIV-1, which has been demon-
strated to be the most effective for virus transmission. In this model,
we exploited the expression of the GFP to identify the modiﬁed target
cells that have been newly infected during the experiment (Fig. 6).
Taken together, the use of the EGFP-CEM-NKr-CCR5-SNAP cell line
makes the RFADCC a faster and more reliable tool for the evaluation of
the cytotoxicity against cells infected with many human and non-
human pathogens, such as HIV-1 and SIV viruses.
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